VIYASH SCIENTIFIC Latest Share Price (VIYASH)
TODAY IN ONE LINE
VIYASH fell 1.1%, in line with Nifty's -0.3% move, supported by recent strong earnings.
With a market cap of ₹11,227.7 Cr., it trades at a P/E of 61.63. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
VIYASH SCIENTIFIC flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 167.6% and Profit up 279.0%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.14x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 4.9%
- ●Expensive ValuationTrading at a high P/E ratio of 71.2x
- ●Low Promoter HoldingPromoters hold only 0.1%
- ●Promoter SellingPromoter holding decreased by 61.22% QoQ
Latest VIYASH SCIENTIFIC News
What changed recently?
Recent events, corporate actions, and announcements.
VIYASH SCIENTIFIC valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for VIYASH SCIENTIFIC, framed against the sector median so the premium or discount is obvious at a glance.
VIYASH SCIENTIFIC trades at a P/E of 61.63× and P/B of 3.86×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
VIYASH SCIENTIFIC technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for VIYASH SCIENTIFIC — derived from the latest tape, not yesterday's close.
VIYASH SCIENTIFIC last traded at ₹257.6 with an intraday range of ₹253.5–₹259.35 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹257.60| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 271.83 | +14.23 | +5.53% |
| R3 | 265.98 | +8.38 | +3.25% |
| R2 | 262.67 | +5.07 | +1.97% |
| R1 | 260.13 | +2.53 | +0.98% |
| PIVOT | 256.82 | -0.78 | -0.30% |
| CURRENT | 257.60 | — | — |
| S1 | 254.28 | -3.32 | -1.29% |
| S2 | 250.97 | -6.63 | -2.58% |
| S3 | 248.43 | -9.17 | -3.56% |
| S4 | 242.58 | -15.02 | -5.83% |
VIYASH is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹255.35–₹259.35
Trading Inside opening range
VIYASH SCIENTIFIC financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for VIYASH SCIENTIFIC — consolidated or standalone — with margins, YoY growth and key ratios inline.
VIYASH SCIENTIFIC reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹11,227.7 Cr. and reported EPS of ₹1.51.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 1,551 | 3,420 ▲ 120.5% |
| Sales Growth YoY %Derived | 13.26% | 120.47% |
| Other Income | 15 | 44 ▲ 196.5% |
| Total Income | 1,566 | 3,464 ▲ 121.2% |
| 812 | 1,563 ▲ 92.5% | |
| Gross ProfitDerived | 740 | 1,858 ▲ 151.2% |
| Gross Margin %Derived | 47.67% | 54.31% |
| 578 | 1,205 ▲ 108.6% | |
| EBITDA (Operating Profit)Derived | 162 | 653 ▲ 303.3% |
| OPM %Derived | 10.43% | 19.08% |
| 122 | 259 ▲ 111.6% | |
| Profit Before Tax (PBT) | 44 | 349 ▲ 687.7% |
| 12 | 124 ▲ 932.1% | |
| Effective Tax %Derived | 27.19% | 35.63% |
| Profit/Loss from Discontinued Ops | — | — |
| Total Profit for Period | 32 | 225 ▲ 596.4% |
| Less: Non-controlling Interests | 10 | 47 ▲ 356.4% |
| Net Profit (Owner's PAT)Derived | 22 | 177 ▲ 710.2% |
| Net Profit Margin %Derived | 1.41% | 5.18% |
| PAT Growth YoY %Derived | 161.00% | 710.24% |
| Earnings Per Share (EPS ₹) | 0.87 | 4.06 ▲ 366.7% |
| Diluted Shares Outstanding (Cr) | 25 | 44 ▲ 74.5% |
| Other Comprehensive Income (Net of Tax) | -22 | 107 ▲ 594.7% |
| Total Expenses (incl. D&A & Interest) | 1,522 | 3,115 ▲ 104.7% |
| Material Cost % of RevenueDerived | 39.80% | 40.26% |
| Employee Cost % of RevenueDerived | 18.12% | 16.53% |
| Other Cost % of RevenueDerived | 19.12% | 18.70% |
| Interest Coverage (x)Derived | 1.57x | 6.05x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 849 | 1,039 ▲ 22.4% | 1,179 ▲ 13.5% | 1,362 ▲ 15.5% | 1,413 ▲ 3.8% | 1,421 ▲ 0.6% | 1,370 ▼ 3.6% | 1,551 ▲ 13.3% | 3,420 ▲ 120.5% | |
| Sales Growth YoY %Derived | — | 22.35% | 13.46% | 15.47% | 3.76% | 0.57% | -3.60% | 13.26% | 120.47% | |
| Other Income | 17 | 9 ▼ 47.7% | 10 ▲ 16.3% | 8 ▼ 17.1% | 11 ▲ 29.7% | 6 ▼ 41.1% | 11 ▲ 71.5% | 15 ▲ 34.1% | 44 ▲ 196.5% | |
| Total Income | 866 | 1,048 ▲ 21.0% | 1,189 ▲ 13.5% | 1,370 ▲ 15.2% | 1,424 ▲ 3.9% | 1,427 ▲ 0.3% | 1,381 ▼ 3.3% | 1,566 ▲ 13.4% | 3,464 ▲ 121.2% | |
462 | 543 ▲ 17.4% | 605 ▲ 11.4% | 695 ▲ 14.8% | 793 ▲ 14.2% | 834 ▲ 5.1% | 760 ▼ 8.9% | 812 ▲ 6.9% | 1,563 ▲ 92.5% | ||
| Gross ProfitDerived | 387 | 496 ▲ 28.3% | 574 ▲ 15.7% | 667 ▲ 16.2% | 620 ▼ 7.1% | 587 ▼ 5.3% | 610 ▲ 3.9% | 740 ▲ 21.2% | 1,858 ▲ 151.2% | |
| Gross Margin %Derived | 45.55% | 47.75% | 48.69% | 48.98% | 43.87% | 41.32% | 44.53% | 47.67% | 54.31% | |
304 | 371 ▲ 22.2% | 404 ▲ 8.8% | 455 ▲ 12.6% | 510 ▲ 12.2% | 575 ▲ 12.7% | 549 ▼ 4.6% | 578 ▲ 5.3% | 1,205 ▲ 108.6% | ||
| EBITDA (Operating Profit)Derived | 83 | 125 ▲ 50.6% | 170 ▲ 36.3% | 212 ▲ 24.5% | 109 ▼ 48.4% | 12 ▼ 89.1% | 61 ▲ 413.7% | 162 ▲ 163.4% | 653 ▲ 303.3% | |
| OPM %Derived | 9.77% | 12.02% | 14.44% | 15.57% | 7.74% | 0.84% | 4.48% | 10.43% | 19.08% | |
73 | 75 ▲ 2.5% | 86 ▲ 15.5% | 66 ▼ 23.4% | 67 ▲ 1.1% | 26 ▼ 60.5% | 92 ▲ 249.2% | 122 ▲ 32.5% | 259 ▲ 111.6% | ||
| Profit Before Tax (PBT) | 24 | 59 ▲ 149.0% | 94 ▲ 59.8% | 137 ▲ 45.2% | 53 ▼ 60.9% | -138 ▼ 357.9% | -55 ▲ 60.3% | 44 ▲ 181.1% | 349 ▲ 687.7% | |
13 | 2 ▼ 85.1% | 12 ▲ 499.4% | 32 ▲ 167.5% | 8 ▼ 74.1% | -16 ▼ 288.3% | -25 ▼ 59.6% | 12 ▲ 148.1% | 124 ▲ 932.1% | ||
| Effective Tax %Derived | 56.91% | 3.41% | 12.79% | 23.55% | 15.60% | 11.39% | 45.81% | 27.19% | 35.63% | |
| Profit/Loss from Discontinued Ops | 421 | — ▼ 100.0% | — | — | — | — | — | — | — | |
| Total Profit for Period | 431 | 57 ▼ 86.8% | 82 ▲ 44.3% | 104 ▲ 27.3% | 45 ▼ 56.9% | -122 ▼ 370.7% | -30 ▲ 75.7% | 32 ▲ 208.9% | 225 ▲ 596.4% | |
| Less: Non-controlling Interests | 9 | 8 ▼ 11.2% | 12 ▲ 47.8% | 9 ▼ 25.8% | 4 ▼ 57.7% | -1 ▼ 121.5% | 6 ▲ 864.8% | 10 ▲ 65.9% | 47 ▲ 356.4% | |
| Net Profit (Owner's PAT)Derived | 422 | 49 ▼ 88.5% | 70 ▲ 43.7% | 95 ▲ 36.5% | 41 ▼ 56.8% | -121 ▼ 393.7% | -36 ▲ 70.4% | 22 ▲ 161.0% | 177 ▲ 710.2% | |
| Net Profit Margin %Derived | 49.63% | 4.68% | 5.93% | 7.01% | 2.92% | -8.53% | -2.62% | 1.41% | 5.18% | |
| PAT Growth YoY %Derived | — | -88.46% | 43.66% | 36.53% | -56.78% | -393.71% | 70.40% | 161.00% | 710.24% | |
| Earnings Per Share (EPS ₹) | 17.30 | 1.97 ▼ 88.6% | 2.81 ▲ 42.6% | 3.84 ▲ 36.7% | 1.66 ▼ 56.8% | -4.86 ▼ 392.8% | -1.44 ▲ 70.4% | 0.87 ▲ 160.4% | 4.06 ▲ 366.7% | |
| Diluted Shares Outstanding (Cr) | 25 | 25 ▲ 0.4% | 25 ▲ 0.6% | 25 ▲ 0.0% | 25 ▲ 0.0% | 25 ▲ 0.4% | 25 ▲ 0.0% | 25 ▲ 0.3% | 44 ▲ 74.5% | |
| Other Comprehensive Income (Net of Tax) | -139 | -54 ▲ 61.3% | -32 ▲ 40.8% | 64 ▲ 302.7% | -109 ▼ 268.7% | -26 ▲ 75.9% | -65 ▼ 149.2% | -22 ▲ 66.8% | 107 ▲ 594.7% | |
| Total Expenses (incl. D&A & Interest) | 841 | 989 ▲ 17.6% | 1,095 ▲ 10.7% | 1,233 ▲ 12.6% | 1,370 ▲ 11.1% | 1,565 ▲ 14.2% | 1,435 ▼ 8.3% | 1,522 ▲ 6.0% | 3,115 ▲ 104.7% | |
| Material Cost % of RevenueDerived | 40.57% | 43.67% | 43.14% | 43.23% | 47.46% | 48.78% | 44.80% | 39.80% | 40.26% | |
| Employee Cost % of RevenueDerived | 13.40% | 14.04% | 14.00% | 13.75% | 16.38% | 18.18% | 18.29% | 18.12% | 16.53% | |
| Other Cost % of RevenueDerived | 22.38% | 21.69% | 20.25% | 19.66% | 19.75% | 22.30% | 21.76% | 19.12% | 18.70% | |
| Interest Coverage (x)Derived | 1.26x | 2.53x | 3.35x | 6.62x | 3.70x | -1.23x | -0.00x | 1.57x | 6.05x |
VIYASH SCIENTIFIC segment analysis : revenue and profit mix.
Disclosed business segments at VIYASH SCIENTIFIC with their share of revenue and profit, switchable between consolidated and standalone reporting.
VIYASH SCIENTIFIC discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for VIYASH SCIENTIFIC.
Our AI distills the core fundamental drivers supporting VIYASH SCIENTIFIC, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 80 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
VIYASH SCIENTIFIC peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — VIYASH SCIENTIFIC is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
VIYASH SCIENTIFIC chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for VIYASH SCIENTIFIC — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
VIYASH SCIENTIFIC delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for VIYASH SCIENTIFIC over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in VIYASH SCIENTIFIC stood at 51.3% of traded volume, against a 20-day average of 52.2%.
VIYASH SCIENTIFIC announcements: results, concalls, ratings, M&A.
Filings VIYASH SCIENTIFIC sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
VIYASH SCIENTIFIC files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 65 documents below.
General Updates
Update on proposed acquisition of BioForLife Italia S.r.l
General Updates
Viyash Scientific Limited has informed the Exchange about ESOP Allotment
Analysts/Institutional Investor Meet/Con. Call Updates
Viyash Scientific Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates
Viyash Scientific Limited has informed the Exchange about Link of Earning call Recording
Copy of Newspaper Publication
Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication for Q1 FY 27 Financial Results.
Investor decks & rating reports.
VIYASH SCIENTIFIC dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue VIYASH SCIENTIFIC has declared, sequenced by announce and record date.
VIYASH SCIENTIFIC corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About VIYASH SCIENTIFIC: business, sector, key facts.
What VIYASH SCIENTIFIC does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
VIYASH SCIENTIFIC is a listed Indian equity, listed as NSE: VIYASH, BSE: 512529.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AAREY DRUGS & PHARM (AAREYDRUGS) Share PricePeer
- AARTI DRUGS (AARTIDRUGS) Share PricePeer
- AARTI PHARMALABS (AARTIPHARM) Share PricePeer
- AJANTA PHARMA (AJANTPHARM) Share PricePeer
- AKUMS DRUGS AND PHARMA L (AKUMS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about VIYASH SCIENTIFIC (VIYASH).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of VIYASH SCIENTIFIC (VIYASH)?
The current share price of VIYASH SCIENTIFIC (VIYASH) is ₹257.60. Today, the stock has declined by ₹2.85 (1.09%), trading in a range of ₹253.50 to ₹259.35. The stock opened at ₹259.30 with a trading volume of 18,59,725 shares.
02Is VIYASH SCIENTIFIC stock a good investment for long-term?
VIYASH SCIENTIFIC can be considered for long-term investment based on several factors. The company has a market capitalization of ₹11,227.7 Cr., P/E ratio of 61.63, ROE of 4.88%, and ROCE of 4.99%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of VIYASH SCIENTIFIC stock?
The 52-week high price of VIYASH SCIENTIFIC (VIYASH) is ₹298.00, while the 52-week low is ₹178.13. Currently trading at ₹257.60, the stock is 44.61% above its 52-week low and 13.56% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy VIYASH SCIENTIFIC stock at the current price?
Whether to buy VIYASH SCIENTIFIC stock at ₹257.60 depends on multiple factors. The stock is currently trading with a P/E ratio of 61.63 and P/B ratio of 3.86. Today's performance shows a loss of 1.09%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of VIYASH SCIENTIFIC and when is the next dividend?
VIYASH SCIENTIFIC offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹257.60, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of VIYASH SCIENTIFIC?
VIYASH SCIENTIFIC's key financial metrics include: P/E Ratio: 61.63, P/B Ratio: 3.86, ROE: 4.88%, ROCE: 4.99%, Dividend Yield: 0%, EPS: ₹1.51, Book Value: ₹71.30, and Debt-to-Equity: 0.14. The company's market cap stands at ₹11,227.7 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is VIYASH SCIENTIFIC stock performing today in the market?
VIYASH SCIENTIFIC stock opened at ₹259.30 and is currently trading at ₹257.60, showing a decline of ₹2.85 (1.09%). The intraday high is ₹259.35 and low is ₹253.50. The trading volume stands at 18,59,725 shares, indicating strong market participation today.
08What is the P/E ratio of VIYASH SCIENTIFIC and what does it indicate?
VIYASH SCIENTIFIC has a Price-to-Earnings (P/E) ratio of 61.63, which means investors are willing to pay 61.63 for every ₹1 of earnings. With an EPS of ₹1.51, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about VIYASH SCIENTIFIC (VIYASH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.